JF

Joshua M. Fine

Mr. Fine has been an investment banking and finance professional for over 13 years. From 2011 until his appointment as the Company’s Chief Financial Officer, Mr. Fine served as the Vice President/Director, Healthcare Capital Markets, of Scarsdale Equities, LLC (“Scarsdale”). Mr. Fine is also currently the Vice President of Finance and Operations for Icagen, Inc., a biotechnology company, a position he has held since 2017. From 2009 until 2011, Mr. Fine served as the Vice President, Capital Markets of Emerging Growth Equities, a boutique investment banking firm. Mr. Fine holds a Bachelor of Arts in Political Science from Hartwick College.


Org chart


Teams


Offices

This person is not in any offices


Cyclo Therapeutics

Cyclo Therapeutics is a clinical-stage biotechnology company that develops cyclodextrin-based products for the treatment of disease.


Industries

Employees

1-10

Links